• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    ArQule Inc. (ARQL)

    -NasdaqGM
    1.82 Up 0.02(1.11%) 4:00PM EDT
    Add to Portfolio
    Prev Close:1.80
    Open:1.80
    Bid:1.83 x 100
    Ask:1.84 x 400
    1y Target Est:4.50
    Beta:2.31
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:1.80 - 1.87
    52wk Range:1.04 - 2.50
    Volume:109,297
    Avg Vol (3m):479,272
    Market Cap:114.33M
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARQLUp 1.11%114.33M
    ARRYDown 0.13%1.09B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.95
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.33
    Quarterly EPS Est (Jun-15) :-0.08
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):-1.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ArQule, Inc., a clinical-stage biotechnology company, researches and develops therapeutics for the treatment of cancer and rare diseases. Its lead product candidate is tivantinib, a small molecule inhibitor of the c-Met receptor tyrosine kinase an... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback